Optimized Cord Blood Transplant
Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults and Pediatrics
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 54 patients (estimated)
- Sponsors
- Fred Hutchinson / University of Washington Cancer Consortium
- Collaborators
- National Cord Blood Network
- Tags
- Allogeneic Stem Cell Transplant, Cord Blood
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1758
- NCT Identifier
- NCT06013423
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.